FibroGen, Inc Earning Date (FGEN)

USA |NASDAQ |USD

FGEN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 8, 2022 Jun 2022 - - $-1.18
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 8, 2022 Jun 2022 - - $24.36M

Fibrogen, Inc's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.

FGEN Earnings Date & History Chart

FGEN Earnings & Revenue Forecast

FGEN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 10 $-2.42 $-3.87 $-1.43

FGEN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 5 / 3 $-2.79 $-2.79 $-2.31

FGEN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 10 $217.26M $95.50M $299.12M

FGEN Earnings Date & Revenue History

FGEN Earnings History

|
Show More
Show More

FGEN Revenue History

|
Show More
Show More

Fibrogen, Inc Next Earnings Date & Report

FGEN Next Earnings Date & Report Preview: Jun 2022 (FQ)

FGEN's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.

Fibrogen, Inc Previous Earnings Dates & Reports

FGEN Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Fibrogen, Inc's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.

FGEN Previous Earnings Date & Report Recap: Dec 2021 (FY)

Fibrogen, Inc's previous annual earnings date was Feb 28, 2022 for its fiscal year ended Dec 31, 2021.

FGEN's earnings per share (EPS) was $-2.87, missing the consensus analysts forecast of $-2.39 by 20.13% , and lower than the previous year's EPS (Dec 2020) by 34.79%.

Revenues were $235.31M, worse than the forecast of $265.29M by -11.30%, and up by 33.46% from previous year's revenue.

The company reported a net income of $-290.02M.

Fibrogen, Inc reported a free cash flow of $-87.42M for its fiscal year, compared to $77.61M a year ago.

The company ended the fiscal year with $99.73M in total debt, an increase of 164.40% compared to the previous year.